SLC2A1 and neoplasm: The specific Zn(II) overloading in tumor cells can inhibit glycolysis and initiate GLUT1 depletion for energy exhaustion induced tumor therapy, while the “nanoenabled energy interrupter” has negligible impact on Zn(II) homeostasis and energy metabolism in normal cells.